Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 5, 2002
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion
Robert J Soiffer, Edwin P Alyea, Ephraim Hochberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 6, 2017
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement
David Qualls, Andrew Sullivan, Shuli Li, et al.
Blood
|
May 31, 2002
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
Roberto Bellucci, Edwin P Alyea, Edie Weller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 3, 2018
Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes
Zachariah DeFilipp, Fabian M Troschel, David A Qualls, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2004
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
Corey Cutler, Haesook T Kim, Ephraim Hochberg, et al.
Abdominal Radiology (New York)
|
June 18, 2016
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients
Wendy Atkinson, Ciprian Catana, Jeremy S Abramson, et al.
Leukemia & Lymphoma
|
July 12, 2014
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma
Eric Jacobsen, Olga Pozdnyakova, Robert Redd, et al.
Blood
|
April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Vincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Gender, Productivity, and Philanthropic Fundraising in Academic Oncology
Subha Perni, Danielle Bitterman, Jennifer Ryan, et al.
Blood Advances
|
September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
Reem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 5, 2002
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion
Robert J Soiffer, Edwin P Alyea, Ephraim Hochberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 6, 2017
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement
David Qualls, Andrew Sullivan, Shuli Li, et al.
Blood
|
May 31, 2002
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
Roberto Bellucci, Edwin P Alyea, Edie Weller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 3, 2018
Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes
Zachariah DeFilipp, Fabian M Troschel, David A Qualls, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2004
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
Corey Cutler, Haesook T Kim, Ephraim Hochberg, et al.
Abdominal Radiology (New York)
|
June 18, 2016
Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients
Wendy Atkinson, Ciprian Catana, Jeremy S Abramson, et al.
Leukemia & Lymphoma
|
July 12, 2014
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma
Eric Jacobsen, Olga Pozdnyakova, Robert Redd, et al.
Blood
|
April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Vincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Gender, Productivity, and Philanthropic Fundraising in Academic Oncology
Subha Perni, Danielle Bitterman, Jennifer Ryan, et al.
Blood Advances
|
September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma
Reem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Page
of 4